Nutrae NR pre-launch product presentation 02
Nicotinamide Riboside Hydrogen Malate · Capsules planned for the UAE private launch

NR

Nicotinamide riboside hydrogen malate presented as a planned single-ingredient capsule with source-linked research context.

250 mg NRHM salt per capsule100 capsulesHalal statuscGMP status
AED 199SALES STARTING SOON

For three bottles, choose one of the four presentation gift boxes.

SALES STARTING SOON
Product facts

One molecule.
98% purity target.

The launch specification remains under final verification. The signed specification, COA, batch records and applicable certificates will be linked only after they are matched to the exact SKU and lot.

Target launch specification

Pending final verification
Active
Nicotinamide riboside hydrogen malate (NRHM)
Release assay target
98% target
Target amount per capsule
250 mg NRHM salt
Target capsules per bottle
100
Capsule composition
Pending final signed specification
Excipient statement
Pending final signed specification
Filling and stability
Pending verification

View Certificate of Analysis · View Certifications · Batch-record status

Ingredient identity

NRHM is a defined salt form. Nutrae keeps its planned capsule specification separate from studies of other nicotinamide riboside forms.

Explore the complete record

The exact study form, dose, population, measured results and material boundaries are mapped in Nutrae Science.

Open the evidence record
Human evidence

Source-linked study context.

Selected external studies are summarized with their form and limits. No finding is attributed to the planned Nutrae capsule.

Randomized human study · Scientific Reports 2019

NR chloride study: measured NAD⁺ biomarker.

In 140 adults, a study using NR chloride reported dose-responsive changes in measured whole-blood NAD⁺. It did not test NRHM or a finished Nutrae capsule.

100 mg/day
+22%
300 mg/day
+51%
1,000 mg/day
+142%
Study form
NR chloride
Read the primary study
Ca-AKG AED 199 NR AED 199 Urolithin A AED 199